See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 8, 2010

Menstrual Migraines Insomnia Pulmonary Arterial Hypertension (PAH)

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Menstrual Migraines

This study will evaluate the safety and effectiveness of an investigational hormone contraceptive to treat menstrual migraines. The study will consist of five visits over about 20 weeks.

The research site is in Seattle, Wash.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/migraines.aspx.

-----

Insomnia

This study will evaluate a non-invasive device for insomnia. It will last up to eight weeks, involving two office visits and four overnight stays.

The research site is in Glendale, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/insomnia.aspx.

-----

Pulmonary Arterial Hypertension (PAH)

This study is for people with pulmonary arterial hypertension, a rare and debilitating condition that causes high blood pressure in lung blood vessels. Symptoms may include shortness of breath, fatigue, chest pain and rapid heartbeat.

The research site is in Boston, Mass.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/pulmonary_arterial_hypertension.aspx.

-----

Copyright 2010 ClinicalConnection.com. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.